Jun 11, 2020
Leap Therapeutics Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer
May 14, 2020
Leap Therapeutics Reports First Quarter 2020 Financial Results
Apr 23, 2020
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers
Apr 01, 2020
Dr. Roeland Nusse: Gairdner Award Recipient and Bio-Techne Board of Directors Member
Nov 14, 2019
Leap Therapeutics Reports Third Quarter 2019 Financial Results
Aug 27, 2019
AntlerA Leverages Precision-engineered Protein Therapeutic Platform to Harness Body's Regenerative Potential
Mar 18, 2019
Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women's Cancer
Mar 08, 2019
Leap Therapeutics to Present at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer
Jan 14, 2019
Leap Therapeutics Announces an Investigator-Initiated Study of DKN-01 in Patients with DKK1+ Advanced Prostate Cancer
Oct 23, 2018
New Kind of Compound Shows Early Promise against Prostate Cancer
Sep 17, 2018
Samumed And United Therapeutics Announce North American License Agreement For Samumed's IPF Drug Candidate
Apr 09, 2018
Cancer Stem Cells Market Worth $1.6 Billion by 2025 | CAGR: 9.98%: Grand View Research, Inc.
Apr 04, 2018
Surrozen Strengthens Leadership Team with Addition of New CEO and Scientific Co-founder
Dec 13, 2017
WNT Signaling Pathway Inhibitors Therapeutics Pipeline Analysis 2017: Key Players are Samumed, Can-Fite BioPharma & Tactical Therapeutics